Symantec to Bet on Data Archive Biz (Asia)
This article was originally published in PharmAsia News
U.S.-based security software-maker Symantec is looking to increase its Asian data-archiving business, especially in India, in light of the booming Asian clinical and pharmaceutical research sectors. India's clinical research outsourcing market is growing at around 20 percent per year, reports Frost & Sullivan. Symantec believes data-archiving for this and other industries also is growing at the same pace. Asian data management needs in general--not considering Japan--comprises an expanding business growing at around 16.6 percent per year, with India's data needs expanding at 27.7 percent, according to estimates. (Click here for more
You may also be interested in...
Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.
AdvaMed CEO Scott Whitaker shared a letter he sent to member companies voicing support for the ongoing protests around the US against police brutality that were sparked after the killing of George Floyd. “While we continue our single-minded pursuit of medical breakthroughs to treat and cure disease, we must also have a single-minded focus on eradicating the disease of racism in this country and around the world,” Whitaker wrote.
Due to strained resources and the slew of emergency use authorizations being requested by sponsors because of the COVID-19 crisis, the agency will now periodically publish Notices of Availabilities in the Federal Register instead of publishing immediately as the EUAs are handed out. However, companies will still get their NOA letters and can start marketing their products, and the agency will post the announcements sooner on its website.